# A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

> **NCT06303648** · PHASE1 · COMPLETED · sponsor: **Transcend Therapeutics** · enrollment: 40 (actual)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Methylone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06303648
- **Lead sponsor:** Transcend Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-20
- **Primary completion:** 2025-07-13
- **Final completion:** 2025-07-13
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06303648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06303648, "A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06303648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*